03/27/2024 6:00 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 5:39 PM | NovoCure (Subject) Shah Pritesh (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 5:17 PM | GROENHUYSEN WILHELMUS CM (Reporting) NovoCure (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:43 PM | Cordova Ashley (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:33 PM | Giladi Moshe (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:33 PM | Leupin Nicolas (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:35 PM | NovoCure (Issuer) Weinberg Uri (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/22/2024 6:11 AM | NovoCure (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024 6:05 AM | NovoCure (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/22/2024 6:06 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 8:28 AM | FMR LLC (Filed by) NovoCure (Subject)
| Form SC 13G/A | |
01/18/2024 6:01 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/12/2024 3:57 PM | Leonard Frank X (Reporting) NovoCure (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/11/2024 4:15 PM | Leupin Nicolas (Reporting) NovoCure (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/09/2024 6:00 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 6:10 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:10 PM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:23 PM | Giladi Moshe (Reporting) NovoCure (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/11/2023 5:19 AM | Capital World Investors (Filed by) NovoCure (Subject)
| Form SC 13G/A | |
11/28/2023 6:30 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 5:15 AM | BAILLIE GIFFORD & CO (Filed by) NovoCure (Subject)
| Form SC 13G/A | |
11/08/2023 3:22 PM | NovoCure (Issuer) Shah Pritesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 4:15 PM | NovoCure (Issuer) Puri Michal Nath (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/02/2023 3:20 PM | Cordova Ashley (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/26/2023 6:02 AM | NovoCure (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023 6:03 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:23 PM | NovoCure (Issuer) Shah Pritesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:24 PM | GROENHUYSEN WILHELMUS CM (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:24 PM | Cordova Ashley (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:40 PM | Cordova Ashley (Reporting) NovoCure (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023 6:00 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/27/2023 6:02 AM | NovoCure (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/27/2023 6:03 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 7:00 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 3:12 PM | Danziger Asaf (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:13 PM | Cordova Ashley (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:13 PM | Ben Arye Barak (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:14 PM | Burke William Patrick (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:14 PM | NovoCure (Issuer) Shah Pritesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:14 PM | GROENHUYSEN WILHELMUS CM (Reporting) NovoCure (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:15 PM | NovoCure (Issuer) Weinberg Uri (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
06/06/2023 2:45 PM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 11:18 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 7:00 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 3:34 PM | NovoCure (Issuer) Stafford Kristin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:02 AM | NovoCure (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:02 AM | NovoCure (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2023 6:06 AM | NovoCure (Filer)
| Form DEF 14A | |
04/24/2023 6:08 AM | NovoCure (Filer)
| Form DEFA14A | |